Immunocore Holdings Plc ADR
(IMCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,454 | -5,277 | 5,023 | -51,087 | -27,316 |
| Depreciation Amortization | 2,432 | 1,634 | 854 | 4,204 | 3,038 |
| Accounts receivable | -9,330 | -3,341 | 836 | -12,348 | -11,053 |
| Accounts payable and accrued liabilities | -3,874 | -3,587 | 3,342 | 7,272 | 1,388 |
| Other Working Capital | 17,802 | 19,126 | -7,610 | 45,129 | 53,377 |
| Other Operating Activity | 20,367 | 17,844 | -2,010 | 32,891 | 20,578 |
| Operating Cash Flow | $21,943 | $26,399 | $435 | $26,061 | $40,012 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,000 | -20,000 | N/A | -350,000 | -350,000 |
| PPE Investments | -1,460 | -712 | 9,702 | -5,129 | -1,589 |
| Investing Cash Flow | $-15,460 | $-20,712 | $9,702 | $-355,129 | $-351,589 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 402,500 |
| Debt Repayment | N/A | N/A | N/A | -50,000 | N/A |
| Common Stock Issued | 8,087 | 6,221 | 2,551 | 6,800 | 6,250 |
| Other Financing Activity | 0 | 0 | 0 | 387,081 | -13,358 |
| Financing Cash Flow | $8,087 | $6,221 | $2,551 | $343,881 | $395,392 |
| Exchange Rate Effect | 28,112 | 20,294 | 8,426 | -1,708 | 11,326 |
| Beginning Cash Position | 455,731 | 455,731 | 455,731 | 442,626 | 442,626 |
| End Cash Position | 498,413 | 487,933 | 476,845 | 455,731 | 537,767 |
| Net Cash Flow | $42,682 | $32,202 | $21,114 | $13,105 | $95,141 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,943 | 26,399 | 435 | 26,061 | 40,012 |
| Capital Expenditure | -1,460 | -712 | -298 | -5,173 | -1,589 |
| Free Cash Flow | 20,483 | 25,687 | 137 | 20,888 | 38,423 |